Cargando…
SEC is an antiangiogenic virulence factor that promotes Staphylococcus aureus endocarditis independent of superantigen activity
The superantigen staphylococcal enterotoxin C (SEC) is critical for Staphylococcus aureus infective endocarditis (SAIE) in rabbits. Superantigenicity, its hallmark function, was proposed to be a major underlying mechanism driving SAIE but was not directly tested. With the use of S. aureus MW2 expres...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094652/ https://www.ncbi.nlm.nih.gov/pubmed/35544579 http://dx.doi.org/10.1126/sciadv.abo1072 |
_version_ | 1784705586750816256 |
---|---|
author | Kinney, Kyle J. Tang, Sharon S. Wu, Xiao-Jun Tran, Phuong M. Bharadwaj, Nikhila S. Gibson-Corley, Katherine N. Forsythe, Ana N. Kulhankova, Katarina Gumperz, Jenny E. Salgado-Pabón, Wilmara |
author_facet | Kinney, Kyle J. Tang, Sharon S. Wu, Xiao-Jun Tran, Phuong M. Bharadwaj, Nikhila S. Gibson-Corley, Katherine N. Forsythe, Ana N. Kulhankova, Katarina Gumperz, Jenny E. Salgado-Pabón, Wilmara |
author_sort | Kinney, Kyle J. |
collection | PubMed |
description | The superantigen staphylococcal enterotoxin C (SEC) is critical for Staphylococcus aureus infective endocarditis (SAIE) in rabbits. Superantigenicity, its hallmark function, was proposed to be a major underlying mechanism driving SAIE but was not directly tested. With the use of S. aureus MW2 expressing SEC toxoids, we show that superantigenicity does not sufficiently account for vegetation growth, myocardial inflammation, and acute kidney injury in the rabbit model of native valve SAIE. These results highlight the critical contribution of an alternative function of superantigens to SAIE. In support of this, we provide evidence that SEC exerts antiangiogenic effects by inhibiting branching microvessel formation in an ex vivo rabbit aortic ring model and by inhibiting endothelial cell expression of one of the most potent mediators of angiogenesis, VEGF-A. SEC’s ability to interfere with tissue revascularization and remodeling after injury serves as a mechanism to promote SAIE and its life-threatening systemic pathologies. |
format | Online Article Text |
id | pubmed-9094652 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-90946522022-05-26 SEC is an antiangiogenic virulence factor that promotes Staphylococcus aureus endocarditis independent of superantigen activity Kinney, Kyle J. Tang, Sharon S. Wu, Xiao-Jun Tran, Phuong M. Bharadwaj, Nikhila S. Gibson-Corley, Katherine N. Forsythe, Ana N. Kulhankova, Katarina Gumperz, Jenny E. Salgado-Pabón, Wilmara Sci Adv Biomedicine and Life Sciences The superantigen staphylococcal enterotoxin C (SEC) is critical for Staphylococcus aureus infective endocarditis (SAIE) in rabbits. Superantigenicity, its hallmark function, was proposed to be a major underlying mechanism driving SAIE but was not directly tested. With the use of S. aureus MW2 expressing SEC toxoids, we show that superantigenicity does not sufficiently account for vegetation growth, myocardial inflammation, and acute kidney injury in the rabbit model of native valve SAIE. These results highlight the critical contribution of an alternative function of superantigens to SAIE. In support of this, we provide evidence that SEC exerts antiangiogenic effects by inhibiting branching microvessel formation in an ex vivo rabbit aortic ring model and by inhibiting endothelial cell expression of one of the most potent mediators of angiogenesis, VEGF-A. SEC’s ability to interfere with tissue revascularization and remodeling after injury serves as a mechanism to promote SAIE and its life-threatening systemic pathologies. American Association for the Advancement of Science 2022-05-11 /pmc/articles/PMC9094652/ /pubmed/35544579 http://dx.doi.org/10.1126/sciadv.abo1072 Text en Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited. |
spellingShingle | Biomedicine and Life Sciences Kinney, Kyle J. Tang, Sharon S. Wu, Xiao-Jun Tran, Phuong M. Bharadwaj, Nikhila S. Gibson-Corley, Katherine N. Forsythe, Ana N. Kulhankova, Katarina Gumperz, Jenny E. Salgado-Pabón, Wilmara SEC is an antiangiogenic virulence factor that promotes Staphylococcus aureus endocarditis independent of superantigen activity |
title | SEC is an antiangiogenic virulence factor that promotes Staphylococcus aureus endocarditis independent of superantigen activity |
title_full | SEC is an antiangiogenic virulence factor that promotes Staphylococcus aureus endocarditis independent of superantigen activity |
title_fullStr | SEC is an antiangiogenic virulence factor that promotes Staphylococcus aureus endocarditis independent of superantigen activity |
title_full_unstemmed | SEC is an antiangiogenic virulence factor that promotes Staphylococcus aureus endocarditis independent of superantigen activity |
title_short | SEC is an antiangiogenic virulence factor that promotes Staphylococcus aureus endocarditis independent of superantigen activity |
title_sort | sec is an antiangiogenic virulence factor that promotes staphylococcus aureus endocarditis independent of superantigen activity |
topic | Biomedicine and Life Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094652/ https://www.ncbi.nlm.nih.gov/pubmed/35544579 http://dx.doi.org/10.1126/sciadv.abo1072 |
work_keys_str_mv | AT kinneykylej secisanantiangiogenicvirulencefactorthatpromotesstaphylococcusaureusendocarditisindependentofsuperantigenactivity AT tangsharons secisanantiangiogenicvirulencefactorthatpromotesstaphylococcusaureusendocarditisindependentofsuperantigenactivity AT wuxiaojun secisanantiangiogenicvirulencefactorthatpromotesstaphylococcusaureusendocarditisindependentofsuperantigenactivity AT tranphuongm secisanantiangiogenicvirulencefactorthatpromotesstaphylococcusaureusendocarditisindependentofsuperantigenactivity AT bharadwajnikhilas secisanantiangiogenicvirulencefactorthatpromotesstaphylococcusaureusendocarditisindependentofsuperantigenactivity AT gibsoncorleykatherinen secisanantiangiogenicvirulencefactorthatpromotesstaphylococcusaureusendocarditisindependentofsuperantigenactivity AT forsytheanan secisanantiangiogenicvirulencefactorthatpromotesstaphylococcusaureusendocarditisindependentofsuperantigenactivity AT kulhankovakatarina secisanantiangiogenicvirulencefactorthatpromotesstaphylococcusaureusendocarditisindependentofsuperantigenactivity AT gumperzjennye secisanantiangiogenicvirulencefactorthatpromotesstaphylococcusaureusendocarditisindependentofsuperantigenactivity AT salgadopabonwilmara secisanantiangiogenicvirulencefactorthatpromotesstaphylococcusaureusendocarditisindependentofsuperantigenactivity |